Literature DB >> 8518793

Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted.

R Weksberg1, I Teshima, B R Williams, C R Greenberg, S M Pueschel, J E Chernos, S B Fowlow, E Hoyme, I J Anderson, D A Whiteman.   

Abstract

To define the region of 11p15 involved in Beckwith-Wiedemann syndrome (BWS), we have carried out a molecular genetic analysis of six patients with features of BWS and constitutional cytogenetic abnormalities involving chromosome band 11p15. Molecular analysis confirmed the 11p origin of the duplicated material and defined the smallest region of overlap for such duplications, within which a gene involved in BWS must be located. This region encompasses the beta-globin gene complex (HBB) to 11pter. In both of our informative cases, the 11p duplication was found to be of paternal origin. Two BWS associated balanced translocations of 11p15 were studied to localize the breakpoints on 11p15. Somatic cell hybrids, Southern blotting and fluorescent in situ hybridization (FISH) showed that both breakpoints were between D11S12 and the insulin-like growth factor 2 (IGF2) gene. A non-BWS translocation breakpoint was more proximal, between HBB and calcitonin-A (CALCA). Pedigree analysis showed that both BWS associated 11p15 translocations were transmitted by phenotypically normal mothers. The data are compatible with the hypothesis that the BWS gene is imprinted and that the maternally inherited BWS gene is normally suppressed whereas the paternally inherited allele is active. Thus, duplications of paternal origin would lead to increased dosage of the BWS gene. Similarly increased dosage of the BWS gene could account for the findings in maternally inherited 11p15 translocations by altering normal imprinting, so that the translocated maternal allele remains active. This study defines one or more gene loci for BWS on 11p15.5 in the genomic region from D11S12 to IGF2.

Entities:  

Mesh:

Year:  1993        PMID: 8518793     DOI: 10.1093/hmg/2.5.549

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

Review 1.  Mechanisms of genomic imprinting.

Authors:  K Pfeifer
Journal:  Am J Hum Genet       Date:  2000-09-05       Impact factor: 11.025

2.  Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.

Authors:  Adam C Smith; Masako Suzuki; Reid Thompson; Sanaa Choufani; Michael J Higgins; Idy W Chiu; Jeremy A Squire; John M Greally; Rosanna Weksberg
Journal:  Genomics       Date:  2011-11-03       Impact factor: 5.736

3.  Congenital anomalies and childhood cancer in Great Britain.

Authors:  S A Narod; M M Hawkins; C M Robertson; C A Stiller
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 4.  Demystified ... FISH.

Authors:  J J Waters; A L Barlow; C P Gould
Journal:  Mol Pathol       Date:  1998-04

Review 5.  Genomic imprinting: mechanism and role in human pathology.

Authors:  B Tycko
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

Review 6.  Beckwith-Wiedemann syndrome.

Authors:  M Elliott; E R Maher
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

7.  Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation.

Authors:  W W Lam; I Hatada; S Ohishi; T Mukai; J A Joyce; T R Cole; D Donnai; W Reik; P N Schofield; E R Maher
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

8.  Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome.

Authors:  D Catchpoole; W W Lam; D Valler; I K Temple; J A Joyce; W Reik; P N Schofield; E R Maher
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

9.  An efficient study design to test parent-of-origin effects in family trios.

Authors:  Xiaobo Yu; Gao Chen; Rui Feng
Journal:  Genet Epidemiol       Date:  2017-07-20       Impact factor: 2.135

Review 10.  Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.

Authors:  B J Rossiter; C T Caskey
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.